A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 199,683 shares of ABT stock, worth $23.4 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
199,683
Previous 188,809 5.76%
Holding current value
$23.4 Million
Previous $19.6 Million 16.04%
% of portfolio
0.25%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$100.07 - $118.13 $1.09 Million - $1.28 Million
10,874 Added 5.76%
199,683 $22.8 Million
Q2 2024

Jul 30, 2024

BUY
$100.73 - $112.44 $666,026 - $743,453
6,612 Added 3.63%
188,809 $19.6 Million
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $795,662 - $878,774
7,265 Added 4.15%
182,197 $20.7 Million
Q4 2023

Feb 01, 2024

BUY
$90.19 - $110.4 $75,398 - $92,294
836 Added 0.48%
174,932 $19.3 Million
Q3 2023

Oct 30, 2023

BUY
$95.53 - $114.62 $860,438 - $1.03 Million
9,007 Added 5.46%
174,096 $16.9 Million
Q2 2023

Aug 04, 2023

BUY
$100.78 - $112.29 $1.86 Million - $2.08 Million
18,496 Added 12.62%
165,089 $18 Million
Q1 2023

May 02, 2023

BUY
$96.86 - $114.01 $728,387 - $857,355
7,520 Added 5.41%
146,593 $14.8 Million
Q4 2022

Jan 26, 2023

BUY
$95.06 - $111.52 $749,072 - $878,777
7,880 Added 6.01%
139,073 $0
Q3 2022

Oct 19, 2022

BUY
$96.76 - $112.03 $809,010 - $936,682
8,361 Added 6.81%
131,193 $12.7 Million
Q2 2022

Jul 13, 2022

BUY
$102.07 - $123.37 $603,744 - $729,733
5,915 Added 5.06%
122,832 $13.3 Million
Q1 2022

Apr 19, 2022

SELL
$114.02 - $139.04 $89,619 - $109,285
-786 Reduced 0.67%
116,917 $13.8 Million
Q4 2021

Jan 20, 2022

BUY
$115.53 - $141.46 $569,447 - $697,256
4,929 Added 4.37%
117,703 $16.6 Million
Q3 2021

Oct 15, 2021

SELL
$116.66 - $129.06 $111,526 - $123,381
-956 Reduced 0.84%
112,774 $13.3 Million
Q2 2021

Jul 19, 2021

SELL
$105.79 - $124.53 $72,148 - $84,929
-682 Reduced 0.6%
113,730 $13.2 Million
Q1 2021

May 07, 2021

BUY
$108.84 - $128.23 $149,219 - $175,803
1,371 Added 1.21%
114,412 $13.7 Million
Q4 2020

Feb 02, 2021

BUY
$105.0 - $114.42 $12,390 - $13,501
118 Added 0.1%
113,041 $12.4 Million
Q3 2020

Oct 29, 2020

BUY
$91.64 - $111.29 $123,714 - $150,241
1,350 Added 1.21%
112,923 $12.3 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $34,609 - $44,296
-452 Reduced 0.4%
111,573 $10.2 Million
Q1 2020

Apr 21, 2020

SELL
$62.82 - $91.86 $56,663 - $82,857
-902 Reduced 0.8%
112,025 $8.84 Million
Q4 2019

Jan 24, 2020

SELL
$78.51 - $87.4 $12,169 - $13,547
-155 Reduced 0.14%
112,927 $9.81 Million
Q3 2019

Oct 16, 2019

BUY
$81.84 - $88.74 $973,896 - $1.06 Million
11,900 Added 11.76%
113,082 $9.46 Million
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $5.93 Million - $6.91 Million
-81,344 Reduced 44.57%
101,182 $8.51 Million
Q1 2019

May 07, 2019

SELL
$66.22 - $80.06 $6.58 Million - $7.95 Million
-99,302 Reduced 35.23%
182,526 $14.6 Million
Q4 2018

Jan 25, 2019

SELL
$65.56 - $74.27 $2.06 Million - $2.34 Million
-31,458 Reduced 10.04%
281,828 $20.4 Million
Q3 2018

Oct 15, 2018

SELL
$60.81 - $73.36 $856,448 - $1.03 Million
-14,084 Reduced 4.3%
313,286 $23 Million
Q2 2018

Jul 31, 2018

SELL
$57.57 - $63.54 $1.79 Million - $1.98 Million
-31,102 Reduced 8.68%
327,370 $20 Million
Q1 2018

Apr 25, 2018

SELL
$56.27 - $63.62 $5.78 Million - $6.54 Million
-102,725 Reduced 22.27%
358,472 $21.5 Million
Q4 2017

Jan 25, 2018

SELL
$53.68 - $57.47 $1.87 Million - $2 Million
-34,771 Reduced 7.01%
461,197 $26.3 Million
Q3 2017

Oct 27, 2017

BUY
$48.06 - $53.64 $23.8 Million - $26.6 Million
495,968
495,968 $26.5 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.